XOMA XOMA Corp

Price (delayed)

$26.66

Market cap

$310.28M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.92

Enterprise value

$294.94M

XOMA has built a significant portfolio of products that are licensed to and being developed by other biotechnology and pharmaceutical companies. The Company's portfolio of partner-funded programs spans multiple stages ...

Highlights
The company's quick ratio has surged by 99% YoY and by 11% QoQ
The revenue has soared by 73% YoY and by 22% from the previous quarter
XOMA's net income has shrunk by 61% YoY but it has increased by 3% QoQ
The EPS has contracted by 49% YoY but it has grown by 3% from the previous quarter
The company's equity fell by 28% YoY and by 7% QoQ

Key stats

What are the main financial stats of XOMA
Market
Shares outstanding
11.64M
Market cap
$310.28M
Enterprise value
$294.94M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
3.76
Price to sales (P/S)
53.13
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
50.76
Earnings
Revenue
$5.81M
EBIT
-$35.49M
EBITDA
-$34.73M
Free cash flow
-$18.9M
Per share
EPS
-$3.92
Free cash flow per share
-$1.63
Book value per share
$7.08
Revenue per share
$0.5
TBVPS
$18.95
Balance sheet
Total assets
$219.42M
Total liabilities
$137.08M
Debt
$121.05M
Equity
$82.34M
Working capital
$131.35M
Liquidity
Debt to equity
1.47
Current ratio
9.45
Quick ratio
8.8
Net debt/EBITDA
0.44
Margins
EBITDA margin
-597.7%
Gross margin
100%
Net margin
-681.7%
Operating margin
-665.7%
Efficiency
Return on assets
-25.6%
Return on equity
-46.6%
Return on invested capital
-27.7%
Return on capital employed
-17.4%
Return on sales
-610.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

XOMA stock price

How has the XOMA stock price performed over time
Intraday
-1.26%
1 week
8.15%
1 month
5.46%
1 year
61.09%
YTD
44.11%
QTD
12.54%

Financial performance

How have XOMA's revenue and profit performed over time
Revenue
$5.81M
Gross profit
$5.81M
Operating income
-$38.68M
Net income
-$39.61M
Gross margin
100%
Net margin
-681.7%
The revenue has soared by 73% YoY and by 22% from the previous quarter
XOMA's gross profit has soared by 73% YoY and by 22% from the previous quarter
XOMA's net income has shrunk by 61% YoY but it has increased by 3% QoQ
The operating income has plunged by 52% YoY but it has grown by 8% from the previous quarter

Growth

What is XOMA's growth rate over time

Valuation

What is XOMA stock price valuation
P/E
N/A
P/B
3.76
P/S
53.13
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
50.76
The EPS has contracted by 49% YoY but it has grown by 3% from the previous quarter
XOMA's price to book (P/B) is 66% more than its last 4 quarters average of 2.3 and 9% more than its 5-year quarterly average of 3.5
The company's equity fell by 28% YoY and by 7% QoQ
The stock's P/S is 96% above its 5-year quarterly average of 27.5 and 18% above its last 4 quarters average of 45.7
The revenue has soared by 73% YoY and by 22% from the previous quarter

Efficiency

How efficient is XOMA business performance
XOMA's ROE has plunged by 95% YoY and by 5% from the previous quarter
The company's return on invested capital rose by 33% QoQ and by 30% YoY
The ROS has grown by 28% from the previous quarter and by 17% YoY
The return on assets has declined by 22% year-on-year but it has increased by 15% since the previous quarter

Dividends

What is XOMA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for XOMA.

Financial health

How did XOMA financials performed over time
XOMA's total assets is 60% greater than its total liabilities
XOMA's current ratio has surged by 111% year-on-year and by 9% since the previous quarter
The company's quick ratio has surged by 99% YoY and by 11% QoQ
The debt is 47% greater than the equity
The company's equity fell by 28% YoY and by 7% QoQ
The company's debt to equity rose by 5% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.